Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global COVID-19 Diagnostics Market, By Product & Service
7.1. COVID-19 Diagnostics Market, By Product & Service, 2020-2030
7.1.1. Instruments
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Reagents & Kits
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Services
7.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global COVID-19 Diagnostics Market, By Sample Type
8.1. COVID-19 Diagnostics Market, By Sample Type, 2020-2030
8.1.1. Nasopharyngeal (NP) swabs
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Oropharyngeal (OP) swabs
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Nasal swabs
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Blood
8.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global COVID-19 Diagnostics Market, By Test Type
9.1. COVID-19 Diagnostics Market, By Test Type, 2020-2030
9.1.1. Molecular (PCR) Testing
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Antigen-based Testing
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Antibody (Serology) Testing
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global COVID-19 Diagnostics Market, By Mode Type
10.1. COVID-19 Diagnostics Market, By Mode Type, 2020-2030
10.1.1. Point-of-Care (PoC)
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Non Point-of-Care (Non-PoC)
10.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global COVID-19 Diagnostics Market, By End-use Type
11.1. COVID-19 Diagnostics Market, By End-use, 2020-2030
11.1.1. Laboratories
11.1.1.1. Market Revenue and Forecast (2016-2030)
11.1.2. Hospitals
11.1.2.1. Market Revenue and Forecast (2016-2030)
11.1.3. Diagnostic Centers and Clinics
11.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 12. Global COVID-19 Diagnostics Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.1.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.1.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.1.4. Market Revenue and Forecast, By Mode (2016-2030)
12.1.5. Market Revenue and Forecast, By End-use (2016-2030)
12.1.6. U.S.
12.1.6.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.1.6.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.1.6.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.1.6.4. Market Revenue and Forecast, By Mode (2016-2030)
12.1.7. Market Revenue and Forecast, By End-use (2016-2030)
12.1.8. Rest of North America
12.1.8.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.1.8.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.1.8.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.1.8.4. Market Revenue and Forecast, By Mode (2016-2030)
12.1.8.5. Market Revenue and Forecast, By End-use (2016-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.2.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.2.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.2.4. Market Revenue and Forecast, By Mode (2016-2030)
12.2.5. Market Revenue and Forecast, By End-use (2016-2030)
12.2.6. UK
12.2.6.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.2.6.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.2.6.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.2.7. Market Revenue and Forecast, By Mode (2016-2030)
12.2.8. Market Revenue and Forecast, By End-use (2016-2030)
12.2.9. Germany
12.2.9.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.2.9.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.2.9.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.2.10. Market Revenue and Forecast, By Mode (2016-2030)
12.2.11. Market Revenue and Forecast, By End-use (2016-2030)
12.2.12. France
12.2.12.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.2.12.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.2.12.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.2.12.4. Market Revenue and Forecast, By Mode (2016-2030)
12.2.13. Market Revenue and Forecast, By End-use (2016-2030)
12.2.14. Rest of Europe
12.2.14.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.2.14.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.2.14.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.2.14.4. Market Revenue and Forecast, By Mode (2016-2030)
12.2.15. Market Revenue and Forecast, By End-use (2016-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.3.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.3.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.3.4. Market Revenue and Forecast, By Mode (2016-2030)
12.3.5. Market Revenue and Forecast, By End-use (2016-2030)
12.3.6. India
12.3.6.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.3.6.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.3.6.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.3.6.4. Market Revenue and Forecast, By Mode (2016-2030)
12.3.7. Market Revenue and Forecast, By End-use (2016-2030)
12.3.8. China
12.3.8.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.3.8.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.3.8.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.3.8.4. Market Revenue and Forecast, By Mode (2016-2030)
12.3.9. Market Revenue and Forecast, By End-use (2016-2030)
12.3.10. Japan
12.3.10.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.3.10.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.3.10.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.3.10.4. Market Revenue and Forecast, By Mode (2016-2030)
12.3.10.5. Market Revenue and Forecast, By End-use (2016-2030)
12.3.11. Rest of APAC
12.3.11.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.3.11.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.3.11.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.3.11.4. Market Revenue and Forecast, By Mode (2016-2030)
12.3.11.5. Market Revenue and Forecast, By End-use (2016-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.4.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.4.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.4.4. Market Revenue and Forecast, By Mode (2016-2030)
12.4.5. Market Revenue and Forecast, By End-use (2016-2030)
12.4.6. GCC
12.4.6.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.4.6.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.4.6.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.4.6.4. Market Revenue and Forecast, By Mode (2016-2030)
12.4.7. Market Revenue and Forecast, By End-use (2016-2030)
12.4.8. North Africa
12.4.8.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.4.8.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.4.8.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.4.8.4. Market Revenue and Forecast, By Mode (2016-2030)
12.4.9. Market Revenue and Forecast, By End-use (2016-2030)
12.4.10. South Africa
12.4.10.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.4.10.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.4.10.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.4.10.4. Market Revenue and Forecast, By Mode (2016-2030)
12.4.10.5. Market Revenue and Forecast, By End-use (2016-2030)
12.4.11. Rest of MEA
12.4.11.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.4.11.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.4.11.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.4.11.4. Market Revenue and Forecast, By Mode (2016-2030)
12.4.11.5. Market Revenue and Forecast, By End-use (2016-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.5.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.5.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.5.4. Market Revenue and Forecast, By Mode (2016-2030)
12.5.5. Market Revenue and Forecast, By End-use (2016-2030)
12.5.6. Brazil
12.5.6.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.5.6.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.5.6.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.5.6.4. Market Revenue and Forecast, By Mode (2016-2030)
12.5.7. Market Revenue and Forecast, By End-use (2016-2030)
12.5.8. Rest of LATAM
12.5.8.1. Market Revenue and Forecast, By Product & Service (2016-2030)
12.5.8.2. Market Revenue and Forecast, By Sample Type (2016-2030)
12.5.8.3. Market Revenue and Forecast, By Test Type (2016-2030)
12.5.8.4. Market Revenue and Forecast, By Mode (2016-2030)
12.5.8.5. Market Revenue and Forecast, By End-use (2016-2030)
Chapter 13. Company Profiles
13.1. Hologic Inc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. F. Hoffman-La Roche Ltd.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Perkin Elmer, Inc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Veredus Laboratories
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. 1drop Inc
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. ADT Biotech Sdn Bhd
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Laboratory Corporation of America Holdings
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. bioMérieux SA.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Danaher
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. Mylab Discovery Solutions Pvt. Ltd.
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
13.12. Neuberg Diagnostics
13.12.1. Company Overview
13.12.2. Product Offerings
13.12.3. Financial Performance
13.12.4. Recent Initiatives
13.13. ALDATU BIOSCIENCES
13.13.1. Company Overview
13.13.2. Product Offerings
13.13.3. Financial Performance
13.13.4. Recent Initiatives
13.14. Quidel Corporation.
13.14.1. Company Overview
13.14.2. Product Offerings
13.14.3. Financial Performance
13.14.4. Recent Initiatives
13.15. Quest Diagnostics
13.15.1. Company Overview
13.15.2. Product Offerings
13.15.3. Financial Performance
13.15.4. Recent Initiatives
13.16. Abbott
13.16.1. Company Overview
13.16.2. Product Offerings
13.16.3. Financial Performance
13.16.4. Recent Initiatives
13.17. altona Diagnostics GmbH
13.17.1. Company Overview
13.17.2. Product Offerings
13.17.3. Financial Performance
13.17.4. Recent Initiatives
13.18. Luminex Corporation
13.18.1. Company Overview
13.18.2. Product Offerings
13.18.3. Financial Performance
13.18.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
Glossary of Terms